Screener
QQMG vs PJP
Invesco ESG NASDAQ 100 ETF vs Invesco Pharmaceuticals ETF
Key differences
- QQMG costs 0.37% less per year.
- Over the last 3 years, QQMG has delivered higher annualized returns.
- PJP has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| QQMG | PJP | |
|---|---|---|
| Annual cost (TER) | 0.20% | 0.57% |
| Fund size (AUM) | $187M | $334M |
| Since | 2021 | 2005 |
| Dividend yield | 0.38% | 1.01% |
| Asset class | equity | equity |
| Region | — | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +42.9% | +38.9% |
| CAGR 3Y | +31.2% | +14.0% |
| CAGR 5Y | N/A | +7.4% |
| Sharpe 3Y | 1.26 | 0.69 |
| Volatility 1Y | 16.91% | 16.19% |
| Max drawdown | -35.43% | -33.95% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to QQMG and PJP
Explore further